San Francisco Bay Area biotech stories.
Tuesday, October 4, 2011
SciClone to buy back $20 million in stock
SciClone Pharmaceuticals Inc. will repurchase up to $20 million of its outstanding common stock over the next 24 months, the Foster City company said Tuesday.
SciClone’s stock (NASDAQ: SCLN) closed Tuesday at $3.74 per share, up nearly 7.8 percent.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)